Nasdaq
RGEN
Repligen Corporation
- Health Care
- Listed 1986
- 1 day
- +0.5%
- 1 month
- +14.0%
- 1 year
- +42.2%
$159.44 · Mkt cap $9.00B · P/E 185.4
At the 6 Aug 2026 close
Nasdaq
Repligen Corporation
$159.44 · Mkt cap $9.00B · P/E 185.4
At the 6 Aug 2026 close
Repligen Corporation trades under the ticker RGEN on Nasdaq, in the Health Care sector (Biotechnology: Biological Products (No Diagnostic Substances)). It has been listed since 1986. Its market capitalisation is $9.00B. The last closing price was $159.44, on 6 Aug 2026. It trades at 185.4 times its last reported annual diluted earnings per share. Over the past year the share price is +42.2%, and +14.0% over the past month. Returns are price returns and exclude dividends.
This page exists because RGEN is one of the shares What A Share can show you. It is not a recommendation, and its appearance here says nothing about whether the company is worth owning.